These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 38781293)

  • 21. Antiretroviral therapy reduces but does not normalize immune and vascular inflammatory markers in adults with chronic HIV infection in Kenya.
    Temu TM; Zifodya JS; Polyak SJ; Wagoner J; Wanjalla CN; Masyuko S; Nyabiage J; Kinuthia J; Bloomfield GS; Page ST; Farquhar C
    AIDS; 2021 Jan; 35(1):45-51. PubMed ID: 33055570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac and Renal Comorbidities in Aging People Living With HIV.
    McCutcheon K; Nqebelele U; Murray L; Thomas TS; Mpanya D; Tsabedze N
    Circ Res; 2024 May; 134(11):1636-1660. PubMed ID: 38781295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelial mitochondrial senescence accelerates cardiovascular disease in antiretroviral-receiving HIV patients.
    Chen YF; Dugas TR
    Toxicol Lett; 2019 Dec; 317():13-23. PubMed ID: 31562912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-sensitivity C-reactive protein among people living with HIV on highly active antiretroviral therapy: a systemic review and meta-analysis.
    Mabhida SE; Mchiza ZJ; Mokgalaboni K; Hanser S; Choshi J; Mokoena H; Ziqubu K; Masilela C; Nkambule BB; Ndwandwe DE; Kengne AP; Dludla PV
    BMC Infect Dis; 2024 Feb; 24(1):160. PubMed ID: 38308222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of age, antiretroviral therapy, and cancer on epigenetic aging in people living with HIV.
    Qing Y; Chan R; Fu P; Cullen J; Miron A; Jacobson JM; Pink J; Gerson SL
    Cancer Med; 2023 May; 12(9):11010-11019. PubMed ID: 36951656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing Cardiovascular Risk in People Living with HIV: Current Tools and Limitations.
    Achhra AC; Lyass A; Borowsky L; Bogorodskaya M; Plutzky J; Massaro JM; D'Agostino RB; Triant VA
    Curr HIV/AIDS Rep; 2021 Aug; 18(4):271-279. PubMed ID: 34247329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV Infection and Risk of Cardiovascular Diseases Beyond Coronary Artery Disease.
    Barnes RP; Lacson JC; Bahrami H
    Curr Atheroscler Rep; 2017 May; 19(5):20. PubMed ID: 28315199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of cardiovascular disease among people living with HIV in sub-Saharan Africa.
    Okello S; Amir A; Bloomfield GS; Kentoffio K; Lugobe HM; Reynolds Z; Magodoro IM; North CM; Okello E; Peck R; Siedner MJ
    Prog Cardiovasc Dis; 2020; 63(2):149-159. PubMed ID: 32035126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Gut Microbiome, Microbial Metabolites, and Cardiovascular Disease in People Living with HIV.
    Peters BA; Burk RD; Kaplan RC; Qi Q
    Curr HIV/AIDS Rep; 2023 Apr; 20(2):86-99. PubMed ID: 36708497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of Cardiovascular Disease in an Aging HIV Population: Where Are We Now?
    Martin-Iguacel R; Llibre JM; Friis-Moller N
    Curr HIV/AIDS Rep; 2015 Dec; 12(4):375-87. PubMed ID: 26423407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV Infection and Incidence of Cardiovascular Diseases: An Analysis of a Large Healthcare Database.
    Alonso A; Barnes AE; Guest JL; Shah A; Shao IY; Marconi V
    J Am Heart Assoc; 2019 Jul; 8(14):e012241. PubMed ID: 31266386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progression of Subclinical Vascular Damage in People Living With HIV Is Not Predicted by Current Cardiovascular Risk Scores: A Prospective 3-Year Study.
    Kapelios CJ; Argyris AA; Protogerou AD; Katsarolis I; Arida A; Papadopoulou M; Ntaroutsou E; Kitas G; Sfikakis PP; Psichogiou M
    J Acquir Immune Defic Syndr; 2020 Apr; 83(5):504-512. PubMed ID: 31923089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noninvasive Cardiovascular Imaging: Emergence of a Powerful Tool for Early Identification of Cardiovascular Risk in People Living With HIV.
    Ryan T; Affandi JS; Gahungu N; Dwivedi G
    Can J Cardiol; 2019 Mar; 35(3):260-269. PubMed ID: 30825948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary Prevention of Cardiovascular Disease for People Living with Human Immunodeficiency Virus.
    Fox CB; Butler K; Flynn D
    Nurs Clin North Am; 2024 Jun; 59(2):219-233. PubMed ID: 38670691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Going Beyond Giving Antiretroviral Therapy: Multimorbidity in Older People Aging with HIV in Nigeria.
    Obimakinde AM; Adebusoye L; Achenbach C; Ogunniyi A; Olaleye D
    AIDS Res Hum Retroviruses; 2020 Mar; 36(3):180-185. PubMed ID: 31711310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association between HIV and atherosclerotic cardiovascular disease in sub-Saharan Africa: a systematic review.
    Hyle EP; Mayosi BM; Middelkoop K; Mosepele M; Martey EB; Walensky RP; Bekker LG; Triant VA
    BMC Public Health; 2017 Dec; 17(1):954. PubMed ID: 29246206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-reported cardiovascular disease risk factor screening among people living with HIV vs. members of the general population in Botswana: a community-based study.
    Molefe-Baikai OJ; Kebotsamang K; Modisawakgomo P; Tlhakanelo JT; Motlhatlhedi K; Moshomo T; Youssouf NF; Masupe T; Gaolathe T; Tapela N; Lockman S; Mosepele M
    BMC Public Health; 2024 Jan; 24(1):198. PubMed ID: 38229024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Clonal Hematopoiesis on Cardiovascular Disease in People Living with HIV.
    Wiley B; Parsons TM; Burkart S; Young AL; Erlandson KM; Tassiopoulos KK; Wu K; Gurnett C; Presti RM; Bolton KL; Challen GA
    Exp Hematol; 2022 Oct; 114():18-21. PubMed ID: 35940373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gut microbiome and cardiometabolic comorbidities in people living with HIV.
    Trøseid M; Nielsen SD; Vujkovic-Cvijin I
    Microbiome; 2024 Jun; 12(1):106. PubMed ID: 38877521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulated IL-32 Expression And Reduced Gut Short Chain Fatty Acid Caproic Acid in People Living With HIV With Subclinical Atherosclerosis.
    El-Far M; Durand M; Turcotte I; Larouche-Anctil E; Sylla M; Zaidan S; Chartrand-Lefebvre C; Bunet R; Ramani H; Sadouni M; Boldeanu I; Chamberland A; Lesage S; Baril JG; Trottier B; Thomas R; Gonzalez E; Filali-Mouhim A; Goulet JP; Martinson JA; Kassaye S; Karim R; Kizer JR; French AL; Gange SJ; Ancuta P; Routy JP; Hanna DB; Kaplan RC; Chomont N; Landay AL; Tremblay CL
    Front Immunol; 2021; 12():664371. PubMed ID: 33936102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.